Study guide
SUN classification, grading and uveitis work-up
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
SUN classification, grading and uveitis work-up
Key Takeaways Explain This Topic AI
Classify uveitis by the predominant inflammatory site and record course separately.
SUN cell and flare grades describe different observations; record hypopyon separately from the cell grade.
Investigations follow the phenotype and history, with treatable infection and masquerade disease considered.
Last updated: October 2026
The Standardization of Uveitis Nomenclature (SUN) Classification
Intraocular inflammatory diseases encompass an extensive spectrum of infectious, autoimmune, and masquerade disorders. Historically, variable clinical definitions and non-standardized grading systems hampered clinical trials and cross-center comparability. In 2005, the Standardization of Uveitis Nomenclature (SUN) Working Group published international consensus guidelines establishing standardized anatomical criteria, descriptors of disease course, and quantitative biomicroscopic grading scales that remain the global benchmark for clinical practice and ophthalmic examinations.
Anatomical Classification
The SUN classification categorizes uveitis strictly according to the primary anatomical site of active inflammation , rather than secondary structural complications:
Anterior Uveitis: The primary site of active inflammation is the anterior chamber . Clinical subtypes include:
Iritis: Inflammation confined exclusively to the iris stroma and anterior chamber.
Iridocyclitis: Inflammation involving both the iris and the anterior portion of the ciliary body (pars plicata).
Anterior Cyclitis: Predominant inflammation of the ciliary body with minimal iris involvement.
Epidemiological context: Represents 50% to 70% of all uveitis presentations in European tertiary centers.
Intermediate Uveitis: The primary site of active inflammation is the vitreous cavity .
Encompasses vitritis, posterior cyclitis, and hyalitis.
Pars Planitis: Defined as a specific idiopathic subset of intermediate uveitis characterized by the presence of "snowball" vitreous opacities and/or "snowbanking" (fibrovascular or inflammatory exudate over the inferior pars plana and peripheral retina) in the complete absence of an identifiable underlying systemic infectious or autoimmune disease.
Posterior Uveitis: The primary site of active inflammation is the retina and/or choroid .
Manifests as focal, multifocal, or diffuse choroiditis, chorioretinitis (choroid primarily inflamed with secondary retinal extension), retinochoroiditis (retina primarily inflamed with secondary choroidal extension), retinitis, or neuroretinitis (retinitis accompanied by optic disc oedema and a macular star).
Panuveitis: Generalized intraocular inflammation with active, concurrent, and roughly equal inflammatory involvement across all three compartments —the anterior chamber, the vitreous cavity, and the retina/choroid. If inflammation predominantly resides in one anatomical zone with only spill-over cells in another, the primary site defines the disease (e.g., severe anterior uveitis with spill-over anterior vitreous cells is classified as anterior uveitis, not panuveitis).
Descriptors of Clinical Course
The SUN Working Group established uniform criteria to define disease onset, duration, and recurrence:
Onset: Categorized as either Sudden (acute, explosive symptomatic onset within hours to days) or Insidious (gradual, indolent, often asymptomatic presentation over weeks or months).
Duration:
Limited: The inflammatory episode resolves completely within ≤ 3 months \le 3\text{ months} ≤ 3 months of onset.
Persistent: The inflammatory process remains active for > 3 months > 3\text{ months} > 3 months .
Clinical Course Classifications:
Acute Uveitis: Characterized by sudden onset and limited duration ( ≤ 3 months \le 3\text{ months} ≤ 3 months ). Example: classical acute HLA-B27-associated anterior uveitis.
Recurrent Uveitis: Characterized by repeated, discrete episodes of inflammation separated by untreated inactive intervals lasting at least ≥ 3 months \ge 3\text{ months} ≥ 3 months off all anti-inflammatory therapy.
Chronic Uveitis: Persistent intraocular inflammation characterized by prompt relapse within < 3 months < 3\text{ months} < 3 months following the discontinuation of topical or systemic therapy. Example: juvenile idiopathic arthritis (JIA)-associated uveitis.
Remission: Defined as completely inactive disease (Grade 0 cells) maintained for ≥ 3 months \ge 3\text{ months} ≥ 3 months while off all anti-inflammatory medications .
Quantitative Biomicroscopic Grading Schemes
Standardized clinical quantification of active inflammation is crucial to gauge therapeutic responsiveness and disease progression.
1. Anterior Chamber Cells (SUN Grading)
Anterior chamber cells are graded with a standard 1 × 1 mm slit beam under consistent examination conditions. SUN cell thresholds should not be conflated with a compulsory fixed magnification or every clinical severity decision.
- SUN Grade Number of Cells in 1 × 1 mm 1\times 1\text{ mm} 1 × 1 mm Field Clinical Significance
- Grade 0 < 1 cell < 1\text{ cell} < 1 cell Complete clinical inactivity / quiet anterior chamber
- Grade 0.5+ 1 – 5 cells 1\text{--}5\text{ cells} 1 – 5 cells Trace residual cellularity; subclinical activity
- Grade 1+ 6 – 15 cells 6\text{--}15\text{ cells} 6 – 15 cells Mild active anterior uveitis
- Grade 2+ 16 – 25 cells 16\text{--}25\text{ cells} 16 – 25 cells Moderate active anterior uveitis
- Grade 3+ 26 – 50 cells 26\text{--}50\text{ cells} 26 – 50 cells Marked active anterior uveitis
Grade 4+ > 50 e x t c e l l s > 50 ext{ cells} > 50 e x t ce ll s ; record hypopyon separately Severe, intense exudative anterior uveitis
Important
Assessing Treatment Response:
Improvement: Defined as a two-step decrease in the level of inflammation (e.g., from Grade 3+ to Grade 1+) or a decrease to Grade 0.
Worsening: Defined as a two-step increase in the level of inflammation (e.g., from Grade 1+ to Grade 3+) or an increase to Grade 4+.
Stable: Changes of only one step (e.g., Grade 2+ to Grade 1+) are considered within inter-observer variability and do not signify true clinical resolution.
2. Anterior Chamber Flare (SUN Grading)
Aqueous flare is optical Tyndall scattering produced by elevated protein concentrations in the aqueous humour secondary to breakdown of the blood-aqueous barrier (tight junctions of the non-pigmented ciliary epithelium and iris capillary endothelium):
SUN Grade Descriptive Biomicroscopic Criteria
Grade 0 None: Slit beam passes invisibly through the anterior chamber; no Tyndall effect.
Grade 1+ Faint: Barely detectable optical haziness within the slit beam compared to normal eye.
Grade 2+ Moderate: Distinct optical flare, but pupillary margin and iris crypt details remain sharply in focus.
Grade 3+ Marked: Dense cloudy flare; iris crypt details, lens architecture, and fundus reflex are distinctly hazy.
Grade 4+ Intense: Plastic aqueous; heavy coagulated fibrin clot formation or complete gelatinous anterior chamber.
Laser Flare Photometry (LFP): Uses automated helium-neon laser scatter to quantify protein leakage in photon counts per millisecond ( ph/ms \text{ph/ms} ph/ms ). Normal values range between 3 and 6 ph/ms \text{ph/ms} ph/ms . Particularly useful in monitoring paediatric uveitis (e.g., juvenile idiopathic arthritis) where persistent subclinical flare correlates with long-term cataract and glaucoma risk.
3. Vitreous Haze Grading (Nussenblatt 0–4+ Scale)
Vitreous haze represents proteinaceous and cellular clouding of the posterior cavity. Unlike vitreous cells (which can settle or persist indefinitely as inactive cellular debris), vitreous haze directly reflects active capillary leakage and blood-retinal barrier breakdown. It is evaluated by indirect ophthalmoscopy with a 20-dioptre condensing lens:
Grade 0: Completely transparent vitreous; nerve fiber layer bundles, small peripapillary retinal vessels, and optic disc margins are crisply demarcated.
Trace: Slight optical dulling of the nerve fiber layer reflex; retinal vessels remain clear.
Grade 1+: Mild haziness; subtle blurring of the optic nerve head margin and secondary retinal vessel bifurcations.
Grade 2+: Moderate haziness; optic nerve head and major retinal vascular arcades are clearly visible, but their fine borders and vessel walls are distinctly blurred.
Grade 3+: Marked haziness; optic nerve head, major retinal vessels, and posterior pole landmarks are barely discernible; retinal details are severely obscured.
Grade 4+: Severe, opaque vitritis; optic nerve head is totally invisible; red reflex is severely diminished or absent.
Granulomatous vs. Non-Granulomatous Inflammation
Differentiating granulomatous from non-granulomatous intraocular inflammation is a fundamental clinical bifurcation in the diagnostic workup:
Keratic Precipitates (KPs)
Keratic precipitates are cellular clusters adhering to the corneal endothelium, transported by convection currents within the anterior chamber (flowing downward along the cooler posterior corneal surface and upward along the warmer iris face):
Mutton-Fat KPs: Large, greasy, waxy, yellowish-white endothelial deposits composed microscopically of transformed macrophages, epithelioid histiocytes, and multinucleated giant cells . With chronicity, they become pigmented, crenated, and ground-glass in texture. Hallmark of granulomatous diseases: sarcoidosis, tuberculosis, syphilis, Vogt-Koyanagi-Harada (VKH) disease, and sympathetic ophthalmia.
Fine Non-Granulomatous KPs: Small, discrete, white, punctate endothelial deposits composed predominantly of lymphocytes, plasma cells, and polymorphonuclear neutrophils . Typical of HLA-B27 acute anterior uveitis, Behçet disease, and trauma.
Stellate KPs: Delicate, translucent, dendritic, star-shaped precipitates scattered uniformly across the entire corneal endothelium (violating Arlt's triangle). Characteristically characteristic for Fuchs Heterochromic Iridocyclitis (FHI / Fuchs Uveitis Syndrome) and Cytomegalovirus (CMV) anterior uveitis .
Endothelial Distribution (Arlt's Triangle): KPs typically settle in an inverted triangular pattern over the inferior one-third to one-half of the corneal endothelium ( Arlt's triangle ) due to gravity and thermal convection currents. Diffuse KPs can suggest viral disease, Fuchs uveitis or other inflammation; their distribution is supportive rather than diagnostic.
Iris Inflammatory Nodules
Koeppe Nodules: Small, discrete, nodular inflammatory cell collections located directly at the pupillary margin , arising from the sphincter pupillae border. Can be observed in both granulomatous and severe non-granulomatous anterior uveitis; act as anchor points for posterior synechiae formation.
Busacca Nodules: Distinct, fleshy, white-yellow cellular nodules located on the anterior iris stroma away from the pupillary border . Composed histopathologically of epithelioid cell granulomas and mononuclear aggregates. Busacca nodules are characteristic for granulomatous uveitis (principally sarcoidosis and tuberculosis) and should be interpreted with the entire phenotype.
Berlin Nodules: Inflammatory nodular infiltrates located within the trabecular meshwork and iridocorneal angle, visualized exclusively on gonioscopy in ocular sarcoidosis.
Tailored Diagnostic Workup in Uveitis
Begin with anatomical site, unilateral/bilateral distribution, onset, recurrence, medication and immune status. Ask about pain, floaters, systemic infection exposure, travel, oral/genital ulcers, inflammatory back pain, joint disease, skin changes, respiratory symptoms, renal disease and neurological symptoms. Examine pressure, keratic precipitates, iris changes, vitreous, retina and choroid. OCT, angiography or ultrasound can resolve a specific question such as oedema, vasculitis or obscured fundus.
Syphilis can mimic many forms and warrants a low testing threshold, commonly broad adult screening with both treponemal and non-treponemal tests. Avoid asserting that every first mild episode in every adult or child requires an identical panel. Positive tests need interpretation of stage and previous treatment. IGRA supports TB exposure but cannot distinguish latent from active infection or establish ocular TB alone. Chest imaging and sarcoid tests follow phenotype and risk; ACE is affected by age, medication and other disease. HLA-B27 is useful in compatible recurrent/severe anterior disease, with assessment of spondyloarthritis symptoms. ANA identifies JIA-associated risk in the appropriate context, rather than diagnosing JIA in every child with uveitis.
Toxoplasma serology supports exposure; early disease and immunosuppression complicate interpretation. A positive IgG alone does not establish the cause of an active lesion. Aqueous/vitreous PCR can help in hypertensive anterior disease or necrotising retinitis, but sampling timing, prior treatment and assay sensitivity matter: a negative result does not always exclude infection.
Persistent atypical vitritis, sub-RPE lesions or unexplained steroid-dependent recurrence can suggest lymphoma. Coordinate sampling with pathology for cytology, flow, cytokines and molecular tests before giving steroids where clinically feasible. IL-10 or a mutation result supports but does not alone prove every diagnosis. Broad untargeted panels produce incidental positives; state how each investigation will change the differential or treatment.